Quantcast
Channel: XconomyRegenerative Medicine – Xconomy
Browsing all 106 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

Fujifilm Snaps Up Cellular Dynamics To Grow Stem Cell Business

Jeff Engel Cellular Dynamics International, an up-and-coming player in the stem cell field and one of Wisconsin’s more promising biotech companies, is being acquired by Fujifilm for $307 million in...

View Article


Image may be NSFW.
Clik here to view.

The Story Behind Cellular Dynamics’ Sale to Fujifilm

Jeff Engel Last week, Cellular Dynamics International CEO Bob Palay described the $307 million acquisition of his company by Fujifilm as a union of two businesses that “share a common strategic vision...

View Article


Image may be NSFW.
Clik here to view.

Stanford Spins Out Immunotherapy Work Funded By CIRM’s Millions

A new cancer immunotherapy company has spun out of Stanford University with backing from a quartet of venture investors and a big hand from the taxpayers of California. The Palo Alto, CA-based firm,...

View Article

Image may be NSFW.
Clik here to view.

San Antonio’s Incell, Belgian Investor Hatch JV for Bio Products

San Antonio — [Corrected 6/10/16, 11:10 a.m. See Below.] Incell, a contract manufacturer for the biotech industry for two decades, is starting a new business with a Belgian investor. Its purpose: to...

View Article

Image may be NSFW.
Clik here to view.

Metis Foundation, Targeting Military Researchers, Plans Fund Raise

San Antonio — [Corrected 1:20 p.m. See below.] A San Antonio nonprofit that aims to help medical researchers earn grants is beginning to raise money for a program that it says may be able to provide...

View Article


Image may be NSFW.
Clik here to view.

California Agency Awards Humacyte $9.9M for Blood Vessel Technology

Humacyte hopes its regenerative medicine approach to blood vessels can offer a better and longer-lasting alternative to synthetic implants used to replace blocked veins. Now it has $9.9 million more...

View Article

Image may be NSFW.
Clik here to view.

With $6M Investment, Histogen Aims to Grow Hair Business in China

Histogen, a San Diego-based regenerative medicine company with technology for growing skin cells and related products, said it has raised $6 million from an affiliate of Huapont Life Sciences, a...

View Article

Image may be NSFW.
Clik here to view.

Cellular Dynamics Says It Will Split Into Two Business Units

Cellular Dynamics International, a Madison, WI-based manufacturer of human cells, said on Thursday that it has divided the company into two business units, one for therapeutics and the other for life...

View Article


Image may be NSFW.
Clik here to view.

Owl Manor’s Regenerative Medicine Veterinary Tech Lands $1.2M Round

Regenerative medicine techniques offer ways to tap into the body’s own healing abilities to treat injuries. Owl Manor Veterinary says its technology offers a better alternative to other biological...

View Article


Image may be NSFW.
Clik here to view.

Progenerative Plans Bone, Business Growth From Revived Acelity Tech

San Antonio — After any acquisition, jobs can be lost, programs are cut, and the business changes its focus. That was true in the years after Kinetic Concepts was acquired by a private equity group...

View Article

Image may be NSFW.
Clik here to view.

BioBridge Plans to Grow $7.8M into Large-Scale Stem Cell Production

San Antonio — A San Antonio life sciences nonprofit is working with three other organizations to learn how to produce larger volumes of stem cells, and has received $7.8 million from a military-based...

View Article

Image may be NSFW.
Clik here to view.

Tour of Texas: Twyla, Firefly, Factom, DocSynk, Disruptors, & More

Let’s get caught up with the latest innovation news from Xconomy Texas. Austin: —Factom, a startup that uses blockchain technology to secure and verify data such as public records and business...

View Article

Image may be NSFW.
Clik here to view.

San Antonio’s Fountainhead Raising Money to Back Up Biomed Incubator

A San Antonio venture capital firm that recently created a biotech and medical device incubator is raising additional funding and may make investments in the coming months, according to managing...

View Article


Image may be NSFW.
Clik here to view.

Tenaya Spins Out of Gladstone With $50M to Fight Heart Disease

The human body can’t repair the heart damage that leads to heart failure. But new biopharmaceutical company Tenaya Therapeutics aims to find a way by turning research from the nonprofit Gladstone...

View Article

Image may be NSFW.
Clik here to view.

BlueRock Raises $225M To Repair Heart Damage With Stem Cells

A new stem cell therapeutics company, BlueRock Therapeutics, has launched with $225 million in funding from international healthcare giant Bayer and Versant Ventures. Using work from Nobel Prize...

View Article


Image may be NSFW.
Clik here to view.

Organovo Discloses First Preclinical Data on Human Liver “Patch”

After taking the first steps toward the development of living human liver tissue “patches” for therapeutic use, San Diego-based Organovo (NASDAQ: ONVO) is laying out its pre-clinical data for the...

View Article

Image may be NSFW.
Clik here to view.

Texas Roundup: “1st & Future,” “Pink Tank” Pitch Contests, & More

As we approach Santa’s annual visit—are your milk and cookies ready?—let’s get caught up with the latest innovation news from Xconomy Texas: —The National Football League has teamed up with the Texas...

View Article


Image may be NSFW.
Clik here to view.

Watching for NIH Innovation in 2017—and Drug Pricing, Trade Deals

With the inauguration of Donald Trump as president on January 20th, the editors asked some of our Xconomists to offer their thoughts on “How could the incoming administration significantly affect your...

View Article

Image may be NSFW.
Clik here to view.

Cytori Buys San Antonio-based Azaya’s Drug Delivery Tech for Stock

San Antonio — Cytori Therapeutics, a San Diego, CA-based developer of drugs that use patients’ own fat tissues to make cellular therapies, is buying the assets of San Antonio-based Azaya Therapeutics...

View Article

Image may be NSFW.
Clik here to view.

With $294M, Kamen Hopes to Bring Regenerative Medicine “Up to Scale”

Dean Kamen is, among other things, an inventor, entrepreneur, and leader in the technology and nonprofit fields. The products he and his company, Manchester, NH-based DEKA Research & Development,...

View Article
Browsing all 106 articles
Browse latest View live